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Host-cell factor 1 (HCF-1) is an unusual transcriptional regulator
that undergoes a process of proteolytic maturation to generate N-
(HCF-1N) and C- (HCF-1C) terminal subunits noncovalently associ-
ated via self-association sequence elements. Here, we present the
crystal structure of the self-association sequence 1 (SAS1) including
the adjacent C-terminal HCF-1 nuclear localization signal (NLS). SAS1
elements fromeach of theHCF-1N andHCF-1C subunits form an inter-
digitated ﬁbronectin type 3 (Fn3) tandem repeat structure. We show
that the C-terminal NLS recruited by the interdigitated SAS1 struc-
ture is required for effective formationof a transcriptional regulatory
complex: the herpes simplex virus VP16-induced complex. Thus, HCF-
1N–HCF-1C association via an integrated Fn3 structure permits an NLS
to facilitate formation of a transcriptional regulatory complex.
crystallography | chromatin | nuclear localization sequence
Host cell factor-1 (HCF-1; also known as HCFC1) is a meta-zoan transcriptional regulator. HCF-1 was initially identiﬁed
as a human coactivator for immediate-early gene expression of
herpes simplex virus (HSV) by forming a complex (VP16-induced
complex, VIC) with the HSV protein VP16 and the cellular
transcriptional regulator Oct-1 (1). HCF-1 regulates cell-cycle
progression by mediating associations between DNA-binding
transcription factors and chromatin modifying complexes (2–12).
Many HCF-1 proteins, including all known vertebrate HCF-1s,
undergo a process of proteolytic maturation. Thus, human HCF-1
is synthesized as a 2035-aa precursor, which is cleaved and modi-
ﬁed byO-GlcNAC transferase (13) to generate HCF-1N andHCF-
1C subunits possessing different roles in, for example, cell-cycle
regulation (14). After cleavage, the two resulting HCF-1N and
HCF-1C subunits remain noncovalently associated via two “self-
association sequences” called SAS1 and SAS2: SAS1 is the pri-
mary association element and its sequence is conserved in HCF-1,
whereas SAS2 is secondary, less well conserved, and not consid-
ered in this study (15).
SAS1 is composed of a short 43-aa HCF-1N segment called
SAS1N and a 197-aa HCF-1C segment called SAS1C (Fig. 1A).
Wilson et al. (15) suggested that SAS1C has two tandem ﬁbro-
nectin type 3 (Fn3) repeat structures forming a binding site for
the 43-aa SAS1N to promote HCF-1N–HCF-1C association.
To understand the mechanism of HCF-1 self-association, we
have determined the crystal structure of SAS1 with the neighbor-
ing nuclear localization signal (called here SAS1–NLS). Contrary
to expectation, SAS1N and SAS1C together—not SAS1C alone—
form an integrated tandem Fn3 structure. Furthermore, we show
that the self-association tethers the basic NLS to the HCF-1N
Kelch domain to facilitate VP16-induced complex formation.
Results
Crystal Structure of the HCF-1 SAS1 Self-Association Domain. The
SAS1–NLS crystal structure (Fig. 1B) was determined to 2.7 Å
resolution using the Se single-wavelength anomalous dispersion
(SAD) method (Table S1 and Fig. S1). Fig. S2 details schemati-
cally the different molecules used in this study as well as their
nomenclature (Fig. S2). In the SAS1–NLS crystal structure, there
are two molecules per asymmetric unit, each possessing a different
conformation (Fig. 1C): in one conformation (shown in Fig. 1B
and in gray in Fig. 1C), a part of the NLS (HCF-1 residues 2014–
2020) is well structured; in the other conformation (shown in
green in Fig. 1C), the NLS is disordered. Unless otherwise spe-
ciﬁcally noted, we refer to the conformation with a structured
NLS (Fig. 1B).
The SAS1–NLS crystal structure reveals several interesting
features (Fig. 1B). It is composed of two structural domains: one
domain (Fn3-1) is composed of SAS1N (HCF-1 residues 360–402)
and the N-terminal portion of SAS1C (1806–1885 amino acids),
and the other domain (Fn3-2) consists of the C-terminal portion of
SAS1C (1892–2002 amino acids). These two domains are con-
nected through a structured and highly conserved connecting loop
(1886–1891 amino acids) (Fig. 1C and Figs. S3A and S4B). The
relative orientation between the two domains in the two SAS1–
NLS conformations differs, with the conformation possessing a
disorderedNLS displaying a wider angle between the two domains
(Fig. 1C).
Interestingly, the structured NLS is located between the two
domains (Fig. 1B and Fig. S4). Electrostatic surface presentations
of the two SAS1–NLS conformations reveal highly charged sur-
faces in which the basic NLS in the NLS-containing conformation
forms a highly basic patch (circled in Fig. 1D, Left) that is largely
absent in the disordered NLS conformation (Fig. 1D, Right). Thus,
NLS binding seems to be coordinated with an SAS1 conforma-
tional change in which the two SAS1 domains grasp the NLS by
closing onto each other, thus generating a highly basic surface.
The most striking feature of SAS1–NLS is the binding mode
between SAS1N and SAS1C, in which an interdigitated SAS1N/
SAS1C structure is formed (Fig. 1B). The entire SAS1N and theN-
terminal portion of SAS1C together form a single Fn3 domain
(Fn3-1), whereas the C-terminal portion of SAS1C adopts a ca-
nonical Fn3 structure (Fn3-2) (Fig. 1E and Fig. S3B). Thus, instead
of SAS1C containing an autonomous tandem Fn3 structure as
suggested (15), a tandem Fn3 structure is created by SAS1N and
SAS1C association. Given this interdigitated structure, we refer
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to the region of Fn3-1 originating from SAS1N (i.e., the entirety
of SAS1N) as “Fn3-1N” and that originating from SAS1C as
“Fn3-1C” (Fig. 1B and Fig. S2). Thus, the crystal structure of SAS1–
NLS shows that HCF-1N and HCF-1C associate in an unexpected
binding mode forming a single interdigitated structure from two
distant parts, SAS1N and SAS1C.
Interactions Between SAS1N and SAS1C. Because SAS1N and
SAS1C are highly conserved (Fig. S3A), to understand how the
sequence conservation is correlated with the SAS1–NLS structure,
we colored the highly conserved residues on the surface of the
SAS1N structure in cyan and of the SAS1C structure in green
as shown in Fig. 2, revealing a striking distribution of conserved
residues. In Fn3-1, the conserved residues are mostly located on
the interface between Fn3-1N (compare Fig. 2 A and B) and Fn3-
1C (compare Fig. 2C andE), whereas in Fn3-2, conserved residues
are located on the surface (Fig. 2 B and D–F) as well as in the
interior. At the Fn3-1N and Fn3-1C interface, the conserved res-
idues form a large hydrophobic core (Fig. 3A, I). There are a few
highly conserved residues located on the surface of Fn3-1 and
these residues also appear to be involved in holding Fn3-1N and
Fn3-1C together (Fig. 3A, II).
To examine the contributions of conserved Fn3-1 interface
residues to SAS1 assembly, we mutated Fn3-1 residues and
assayed SAS1 assembly by bacterial cosynthesis and GST pull-
down assay between wild-type and mutant SAS1N and SAS1C
proteins (Fig. 3 B andC). To disrupt the hydrophobic interface, we
generated mutations V382A, W384A and Y393A, L395A in Fn3-
1N, and mutations V1815A, F1864A, V1866A, and V1866E in
Fn3-1C. Although none of the mutations fully disrupted SAS1N
and SAS1C–NLS association, W384A in Fn3-1N and V1866E in
Fn3-1C, two interacting residues, had the greatest effect (Fig. 3B).
The relatively marginal effects of the alanine substitutions may
reﬂect the hydrophobic properties of alanine side chains (Fig. 3B).
To examine the contributions of conserved interacting resi-
dues located on the surface of Fn3-1, we generated the Q396A
and W1812A mutants. W1812A shows a moderate effect on
association, whereas Q396A shows little if any effect (Fig. 3B).
Given the relatively modest effects of the mutations on SAS1
assembly, we next asked if there might be additive effects of
combined mutations on the hydrophobic Fn3-1N and Fn3-1C in-
terface and the interacting Fn3-1 surface. Because the W1812A-
interacting Fn3-1 surface mutation shows a moderate decrease in
SAS1 assembly, we combined this mutation with both Fn3-1N
interface (V382A, W384A, and Y393A) and interacting surface
(Q396A) mutants. Combined, the Fn3-1C W1812A and both
classes of Fn3-1N alanine mutants showed severe defects in SAS1
assembly (Fig. 3C). These data show that Fn3-1N and Fn3-1C
associate through the hydrophobic interface as well as the inter-
acting surface of Fn3-1.
Association Between HCF-1N and HCF-1C via Fn3-1 Promotes
Transcriptional Regulatory Complex Formation. To investigate the
function of HCF-1N and HCF-1C association through forming an
interdigitated Fn3-1 structure, we examined its role in formation of
the VIC transcriptional regulatory complex. HCF-1 forms a VIC
with VP16 and Oct-1 on a so-called TAATGARAT DNA target
sequence (1). VP16 consists of a core region required for VIC
formation and a potent C-terminal transcriptional activation do-
main enriched in acidic amino acids (also known as acidic activa-
tion domain) (Fig. S2C). The N-terminal Kelch domain of HCF-
1N (Fig. 1A and Fig. S2) is responsible for binding the VP16 core
(called VP16ΔAD) and stabilizing a VIC containing VP16ΔAD (16),
but when a VIC is formed with the full-length acidic activation
domain–containing VP16 (VP16ﬂ), HCF-1C sequences (residues
1495–2035) are also important for VIC formation (17). Thus, be-
cause VP16ﬂ VIC formation involves both HCF-1N (the Kelch
domain) and HCF-1C sequences, it provides a functional assay for
Fig. 1. Crystal structure of the HCF-1 SAS1 and NLS. (A) A schematic dia-
gram showing conserved regions of HCF-1 including HCF-1KEL, SAS1N,
basic, HCF-1PRO, acidic, SAS1C, and NLS. The regions used for this study are
shown in red for SAS1N, yellow for SAS1C, and blue for NLS. (B) A ribbon
diagram of SAS1–NLS. SAS1–NLS is composed of two Fn3 domains, Fn3-1
and Fn3-2. SAS1N of HCF-1N (red) and SAS1C of HCF-1C (yellow; as in-
dicated in A) form an interdigitated Fn3-1 structure. A part of the NLS
(blue) is located between the two Fn3 domains and interacts with the β1
strand of Fn3-1 and the β7 strand of Fn3-2. Disordered regions are shown
as dashed lines. (C ) Comparison between two SAS1–NLS conformations in
an asymmetric unit. One conformation without a structured NLS (green) is
more open than the other with a structured NLS (gray). (D) Electrostatic
surface representation of the two SAS1–NLS conformations: with (Left) or
without (Right) structured NLS. Left: the NLS located between Fn3-1 and
Fn3-2 (yellow dashed circle) creates a basic patch (indicated by an arrow).
Right: The basic patch is absent in the molecule where the NLS is disor-
dered. (E ) Fn3-1 and Fn3-2 adopt a canonical Fn3 topology. Topology and
structure diagrams of a canonical Fn3 domain (PDB ID code 3N1M, the Fn3
domain of Brother of CDO [BOC]) (Left), and Fn3-1 (Middle) and Fn3-2
(Right) domains of HCF-1. Fn3-1 is an interdigitated Fn3 structure com-
posed of both SAS1N (β1–β3 strands; shaded gray) and SAS1C (β4–β7
strands; unshaded) component β strands.








SAS1 assembly in an important process—transcriptional regula-
tory complex assembly.
The HCF-1C sequences necessary for VP16ﬂ VIC formation
were largely not deﬁned (17). We therefore ﬁrst tested whether
the SAS1C–NLS used in the structural analysis (residues 1806–
2035) is sufﬁcient to form a VIC with VP16ﬂ. We cotranslated in
vitro an HCF-1N construct containing the Kelch domain and
SAS1N (called HCF-1Kelch–SAS1N) with SAS1C–NLS and per-
formed a VIC formation assay with VP16ΔAD (Fig. 4A, lanes 3–7,
and Fig. S5) and VP16ﬂ (lanes 8–20). Whereas, HCF-1C sequences
are more important for VP16ﬂ than VP16ΔAD VIC formation
(Fig. 4A, compare lanes 4 and 9), the HCF-1C SAS1C–NLS with
cotranslated HCF-1Kelch–SAS1N is sufﬁcient to promote effective
VP16ﬂ VIC formation (compare lanes 9 and 12; note the retarded
VIC mobility in lane 12 from the added presence of SAS1C–NLS
in the VIC). These data suggest that SAS1C–NLS in HCF-1C is
sufﬁcient to promote effective VIC formation with VP16ﬂ.
We next asked whether HCF-1N/HCF-1C association via the
Fn3-1N and Fn3-1C interaction observed in the crystal structure is
critical for VIC formation. We assayed VIC formation with the
HCF-1Kelch–SAS1N (N) mutants NV382A, NW384A, and NQ396A, and
the SAS1C–NLS (C) mutants CW1812A and CV1866E, and with
combined mutants of NV382A+CW1812A, NV384A+CW1812A, and
NQ396A+CW1812A. The two mutations, W384A (NW384A) and
V1866E (NV1866E), which showed the greatest defects in SAS1
assembly in the GST pull-down experiments (Fig. 3B), greatly
impaired the ability of VP16ﬂ to form VICs (Fig. 4A, lanes 14 and
17). Even mutations that exhibited little or moderate effects in the
GST pull-down experiments (i.e., V382A, Q396A, and W1812A)
displayed more pronounced effects in the VIC-formation assay
(Fig. 4A, lanes 13, 15, and 16), suggesting that the VIC-formation
assay is a more sensitive assay for SAS1 assembly than the GST
pull-down assay. Consistent with the GST pull-down assays,
combinedmutants were not able to form aVIC (Fig. 4A, lanes 18–
20; note the residual VIC formation observed is the result of
SAS1C-independent VIC formation as evidenced by the comi-
gration of this VIC with the N-only VIC in lane 9). These data
show that HCF-1N and HCF-1C association through Fn3-1 is
critical for wild-type VP16 VIC formation.
SAS1 is created via the association of SAS1N and SAS1C seg-
ments that form the interdigitated Fn3-1. Supporting the impor-
tance of this interaction, the conserved amino acids in Fn3-1 are
mostly located at the SAS1N and SAS1C interface (Fig. 2). These
observations led us to hypothesize that the principal function of
Fn3-1 is to hold HCF-1N and HCF-1C together. To test this hy-
pothesis, we constructed a fusion protein (called N·C) with the C
terminus of HCF-1Kelch–SAS1N covalently linked to the N terminus
of the HCF-1C_SAS1C–NLS via a six-glycine linker. We then in-
troducedmutations into theN·C fusion protein, hypothesizing that
if the function of Fn3-1 in VIC formation is limited to holding
HCF-1N and HCF-1C together, then the covalent linkage should
rescue the defects of the SAS1N/SAS1C association mutants.
Consistent with this hypothesis, the fusion protein rescued the
VP16ﬂVIC formation activity of the SAS1N (W384A) and SAS1C
(W1812A) mutations either separately or combined (Fig. 4B,
compare lanes 6–8 with lanes 9–11).
We next asked whether the Fn3-1 domain is required at all for
VIC formation by deleting one or the other or both of the Fn3-1N
and Fn3-1C segments in the N·C fusion protein. Although these
deletions cause a change in VIC mobility, they do not affect the
level of VIC formation (Fig. 4B, lanes 12–14). These results
Fig. 2. Surface representations of SAS1–NLS showing highly conserved
residues. Highly conserved residues are shown on the surface of SAS1–NLS.
SAS1N is shown in pink with highly conserved residues indicated in cyan and
SAS1C is shown in gray with conserved residues indicated in green. Most
of conserved residues of Fn3-1 are located at the associating interface be-
tween SAS1N and SAS1C (A–C). Conserved residues of Fn3-2 are distributed
throughout the surface of Fn3-2 (D–F).
Fig. 3. Interactions between SAS1N and SAS1C. (A) Detailed views of the
interactions between SAS1N and SAS1C. The several hydrophobic residues
(Leu372, Val382, Trp384, Tyr393, and Leu395 from Fn3-1N, and Val1815,
Val1825, Phe1864, Val1866, and Phe1883 from Fn3-1C) form a hydrophobic
core at the associating interface (I). Highly conserved Trp (W1812), Arg
(R1865), and Phe (F1877) residues of SAS1C stack onto each other, and wrap
around the β3 strand of SAS1N. The side chain of Gln396 interacts with the
guanidino group of Arg1865 to apparently stabilize the interaction between
Trp1812 and Arg1865 (II). (B and C) Mutating residues involved in SAS1N/
SAS1C interaction can affect the association between SAS1N and SAS1C–NLS.
Residues involved in the interaction between SAS1N and SAS1C were mu-
tated and SAS1N/SAS1C association assessed by GST-pull-down with GST–
SAS1N. Amounts of bound SAS1C–NLS were measured in three replicate
experiments.
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indicate that the sole function of Fn3-1 in VIC formation is in
bringing the HCF-1N and HCF-1C subunits together, which is
consistent with nearly all conserved residues in Fn3-1 being situ-
ated on the interface between Fn3-1N and Fn3-1C. Our data show
that the association of HCF-1N and HCF-1C via an interdigitated
Fn3-1 domain is critical to form a transcription regulatory com-
plex, and that the principal function of Fn3-1 in this role is to hold
the HCF-1N and HCF-1C subunits together.
Nuclear Localization Signal Promotes VP16-Induced Complex Formation.
The ﬁnding that HCF-1C_SAS1C–NLS is required for VP16ﬂ VIC
formation and that the function of Fn3-1 is limited to holding the
HCF-1N and HCF-1C subunits together suggests that the ability to
promote VP16ﬂ VIC formation resides in the Fn3-2–NLS seg-
ment. To dissect the contribution of Fn3-2–NLS toVIC formation,
we generated a series of deletion constructs in the N·C fusion to
exclude the possibility that the deletions destabilize HCF-1N and
HCF-1C association and, as shown in Fig. 5A and summarized in
Fig. 5B, assayed their activities in VIC formation with VP16ΔAD
(Fig. 5A, Upper) or VP16ﬂ (Fig. 5A, Lower). First, we deleted
the entire Fn3-2–NLS region (N·CΔFn3-2Δ2003–2035, lane 4) or its
components: the Fn3-2 domain itself (N·CΔFn3-2, lane 2) or the
region containing the C-terminal NLS (N·CΔ2003–2035, lane 3).
Fn3-2–NLS or NLS region alone deletion, but not Fn3-2 deletion,
interfered with VP16ﬂ but not VP16ΔAD VIC formation (Fig. 5A
Upper and Lower, compare lanes 2–4), suggesting that the NLS
region alone is involved in VP16ﬂ VIC formation.
To assess the contribution of the NLS to VIC formation, we
created N·C molecules (Fig. 5B) that lacked either the NLS
(N·CΔ2014–2035, lane 8) or the region tethering the NLS to Fn3-2
(N·CΔ2003–2013, lane 5). Deleting the NLS but not the tethering
sequence (Fig. 5A, compare lanes 5 and 8) prevented VP16ﬂ
VIC formation. These data suggest that the ability to form
a VIC with VP16ﬂ resides exclusively within the NLS segment.
To dissect the NLS region further, we deleted the structured
region (N·CΔ2014–2020, lane 6) and the rest (N·CΔ2021–2035, lane 7)
of the NLS separately. Interestingly, in these two constructs, al-
though the level of VP16ﬂ VIC formation is decreased, the ability
to form a VIC was not abolished, indicating that the N-terminal
and C-terminal portions of the NLS function redundantly in
VP16ﬂ VIC formation (Fig. 5A, lanes 6 and 7).
Fig. 4. The SAS1N/SAS1C association via Fn3-1 is critical for VP16-induced complex formation. (A) VIC formation assay with wild-type and SAS1N/SAS1C
association surface mutants with DNA probe alone (lane 1) added Oct-1 POU DNA-binding domain (lanes 2–20), VP16ΔAD (lanes 3–7), and VP16ﬂ (lanes 8–20)
proteins. HCF-1 proteins are N in lanes 4 and 9, C in lanes 5 and 10, N·C in lanes 6 and 11, N+C in lanes 7 and 12, and N+C mutants as indicated in lanes 13–20.
N: HCF-1Kelch–SAS1N, C: HCF-1C_SAS1C–NLS, N·C: a covalently linked HCF-1Kelch–SAS1N and HCF-1C_SAS1C–NLS protein, N+C: cotranslated HCF-1Kelch–SAS1N and HCF-
1C_SAS1C–NLS. (B) VIC formation assay of covalently linked SAS1N and SAS1C mutants with VP16ﬂ and Oct-1 POU DNA-binding domain. HCF-1 proteins are none
in lane 1, N in lane 2, C in lane 3, N·C in lane 4, N+C in lane 5, N+C mutants in lanes 6–8, and N·C mutants in lanes 9–14.
Fig. 5. The NLS is required for VP16-induced complex formation with full-length VP16. (A) VIC formation with Oct-1 POU DNA-binding domain, and VP16ΔAD
(Upper) or VP16ﬂ (Lower) of a series of mutants of N·C near Fn3-2 and NLS. (B) A schematic illustrating mutant constructs and their VIC formation abilities
(Left). Fn3-2 is shown in yellow and the structured NLS is shown in deep blue. Basic residues (K2015, R2016, K2028, K2029, and K2031) in the NLS are indicated
as K or R, and their alanine mutations indicated as A.








The HCF-1 NLS (KRPMSSPEMKSAPKKSKADGQ, 2015–
2035 amino acids) is predicted to be of a bipartite form (18) in
which it is the N-terminal part (SKRPMSS, 2014–2020 amino
acids) that is well-structured in one of the conformations in the
crystal. Because the NLS is required for VIC formation only with
VP16ﬂ and the VP16 activation domain is highly acidic, the basic
sequences within the NLS (Fig. S3A) could play a critical role in
forming a VIC with VP16ﬂ. To test this hypothesis, we examined
whether the basic residues in theNLS are critical forVIC formation.
We therefore generated three mutants in which the basic
residues in the N-terminal (Lys2015, Arg2016) or C-terminal
(Lys2028, Lys2029, Lys2031) parts of the NLS are mutated sepa-
rately or in combination and measured the VIC formation ac-
tivities with these mutants. Whereas the separate N-terminal or
C-terminal NLS mutants displayed slightly decreased VIC forma-
tion (Fig. 5, lanes 9 and 10), the combined mutations strongly af-
fected VIC formation (Fig. 5, lane 11). These results suggest that
the twoNLSbasic regions contribute toVIC formationwithVP16ﬂ.
We next asked whether these basic residues required for efﬁ-
cient VIC formation are also critical for the nuclear localization
potential of the NLS. For this purpose, we fused the wild-type
HCF-1_NLS (2003–2035 amino acids) or the mutant HCF-1_
NLS (K2015A-R2016A, K2028A-K2029A-K2031A, and K2015A-
R2016A-K2028A-K2029A-K2031A) to a GST-GFP fusion and
examined subcellular localization after stable synthesis in human
HeLa Flp-In cells as shown in Fig. 6. In this assay, GST-GFP was
localized to the cytoplasm and nucleus (Fig. 6A), whereas the wild-
type GST-GFP-NLS was localized to the nucleus alone (Fig. 6B).
In contrast, theGST-GFP-NLSmutants displayed similar combined
cytoplasmic/nuclear staining as wild-type GST-GFP (compare
Fig. 6 C–E with A) indicating that the basic residues required for
efﬁcient VP16ﬂ VIC formation are also critical for the nuclear
localization. These results indicate that the HCF-1 NLS possesses
a dual function in localizing HCF-1 to the nucleus and promoting
VIC formation.
Discussion
This study shows that the HCF-1N and HCF-1C subunits associate
by forming an integrated SAS1N–SAS1C (i.e., SAS1) structure
composed of tandem Fn3 domains, one Fn3 being an integrated
composite of SAS1N and SAS1C sequences. Furthermore, our
studies reveal that this stable association permits the NLS to
promote formation of a transcription regulatory complex: the
VP16ﬂ-containing VIC.
Although the interaction between two proteins through “strand
complementation” has been observed in other proteins (19), the
SAS1 structure was unexpected because it had been hypothesized
that the SAS1C region alone could form two Fn3 domains and that
these would provide a dynamic surface for reversible interaction
with SAS1N making it possible to regulate HCF-1N and HCF-1C
subunit association (15). Given the evident stability of SAS1N–
SAS1C structure—as evidenced, for example, by its resistance to
numerous different alanine substitutions (Fig. 3)—we suggest that
it is unlikely that the HCF-1N and HCF-1C subunits dissociate and
reassociate once they form the single hybrid Fn3-1 domain, which
we imagine occurs cotranslationally (or soon thereafter). Thus,
SAS1 forms a stable structure, which, in those species in which
HCF-1 proteins undergo proteolysis, probably stably holds the two
generated subunits together.
This understanding leads us to a view inwhich a progenitorHCF-
1 molecule containing what we imagine was a relatively common
tandem Fn3 domain structure had residues added between the β3
and β4 strands of Fn3-1 (Fig. 1E) and that this addition led over
time to the acquisition of multiple elements including the basic and
acidic segments and proteolytic processing region as seen in human
HCF-1 (Fig. 1A). Thus, HCF-1 subunit association probably did
not evolve because there was proteolytic maturation, but rather
that proteolytic maturation evolved because there was an existing
structure—SAS1—to hold the two molecules resulting from pro-
teolytic maturation together.
The stable intersubunit structure revealed here may also exist in
other heterodimeric proteins generated by proteolysis (e.g., the
mixed-lineage leukemia protein) (20). In combination, HCF-1 and
the mixed-lineage leukemia protein apparently establish an evo-
lutionarily attractive mechanism—formation of a single stable
structural domain composed of two distant regions in a large
precursor protein—for stable association of protein subunits
generated by proteolysis.
Although the HCF-1N Kelch domain is sufﬁcient to bind VP16
and to form a VIC with a VP16 molecule lacking its acidic
activation domain, the HCF-1C subunit is additionally required
for robust formation of a VIC with full-length VP16 (17). Un-
expectedly, withinHCF-1C, it is the NLS region alone that plays an
important role in forming aVICwith full-lengthVP16. TheHCF-1
NLS is of a bipartite form such that there are two basic segments.
Interestingly, each of these can promote full-length VP16 VIC
formation (Fig. 5). Thus, it is a basic region of the HCF-1C subunit
that promotes VIC formation when there is an acidic activation
domain present in VP16. This observation suggests that basic
patches in the NLS (but not necessarily the basic patch observed in
the NLS-containing SAS1–NLS conformation; Fig. 1D) function
to overcome an inhibitory effect of the acidic activation domain of
VP16 in forming a VIC. Such an inhibitory effect could be re-
pulsion between the acidic VP16 activation domain and the acidic
DNA in a VIC. Whichever the mechanism, however, these results
show that sequences within an NLS involved in nuclear localiza-
tion can also possess a function other than nuclear localization.
Fig. 6. Nuclear localization potential of the NLS. Nuclear localization of
GST-GFP alone (A), GST-GFP-HCF-1_NLS (B), and the basic residue mutants:
GST-GFP-HCF-1_NLSK2015A/R2016A (C), GST-GFP-HCF-1_NLS K2028A/K2029A/K2031A
(D), and GST-GFP-HCF-1_NLSK2015A/R2016A/K2028A/K2029A/K2031A (E). GFP signal,
DAPI staining, GFP-DAPI merged, and tubulin-DAPI merged are labeled
above the ﬁgure sections.
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Among the domains or regions comprising the SAS1–NLS
structure presented here, a function for Fn3-1 isHCF-1N andHCF-
1C association, and a function for the NLS is nuclear localization
and formation of a transcription regulatory complex. In contrast,
although there is a high degree of surface conservation in the Fn3-2
domain (Fig. 2) suggesting a function conserved in evolution, no
mechanistic activity has been attributed to it. Given that other Fn3
domains are well known to be involved in protein–protein inter-
actions, it may be involved in interacting with other HCF-1 binding
partners (21).
The Fn3-1 and Fn3-2 domains are connected by a very highly
conserved connecting loop (Figs. S3A and S4B). This high-se-
quence conservation suggests that the connecting loop does
more than just connect the two domains. Given that there are
two conformations of the Fn3-1 and Fn3-2 domains depending on
the presence of an ordered NLS, it is possible that the connecting
loop has a role in regulating the opening and closing of the twoFn3
domains on binding of othermolecules such as VP16 to release the
NLS to facilitate nuclear localization and/or transcription complex
formation. Nevertheless, it cannot be ruled out that one or the
other or both of the conformations observed is due to crystal
packing forces.
The NLS-containing SAS1 structure has the NLS positioned
between the Fn3-1 and Fn3-2 domains. We imagine that, in this
conﬁguration, the NLS would need to be repositioned to function
and that such a repositioning could be achieved by a transition to
the open Fn3-1/Fn3-2 conformation. It would be interesting to test
whether an HCF-1–binding protein such as VP16 might induce the
two Fn3 domains to open and thus release and activate the NLS for
either VIC formation or HCF-1–dependent nuclear import of
VP16 (18).
Although the molecular and cellular biology of HCF-1 has been
extensively studied, no atomic resolution structure of HCF-1 has
been reported. This work provides a structural view into the
function and mechanisms of HCF-1.
Materials and Methods
SAS1–NLS was expressed in E.coli, and puriﬁed by Ni afﬁnity, anion exchange,
and gel-ﬁltration chromatography. The crystals were obtained by the hanging-
drop vapor diffusion method and the structure was solved using the SAD
method. The VP16-induced complex formation was measured by electropho-
retic mobility retardation assay. Nuclear localization was performed in HeLa
cells stably transformed via Flpase-induced recombination. The detailed
materials and methods are described in SI Materials and Methods.
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